Cancer drug development
Compass Therapeutics develops antibody-based medicines for cancer. It runs lab research and clinical testing to find treatments that can block signals tumors use to grow and can help the immune system attack cancer.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Compass Therapeutics is a biotechnology company that develops antibody-based drugs, mainly for cancer. Its work centers on finding immune and tumor targets, designing antibodies that can bind to those targets, and testing these candidates in clinical trials. The company does not sell consumer products; its business is built around discovering and advancing medicines that could become prescription therapies.
The company’s main customers are not patients directly, but larger drug companies, hospitals, and eventually doctors and health systems if a drug wins approval. Today it makes money mainly through research partnerships, licensing deals, and the long path to possible future drug sales if its own programs succeed. That means most of its value comes from its pipeline of experimental medicines rather than from a broad commercial product line.
What makes Compass different is its focus on antibody science and on hard-to-treat cancers. In this industry, a company like Compass acts as a drug developer that takes early research forward to the point where a larger partner may help fund development, or where the company itself can pursue approval and commercialization. Its role is to turn lab discoveries into medicines that can be tested in real patients.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more